[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
JAMA Clinical Guidelines Synopsis
May 12, 2015

Screening for Hepatitis C

Author Affiliations
  • 1Section of Hospital Medicine, University of Chicago Medical Center, Chicago, Illinois
JAMA. 2015;313(18):1855-1856. doi:10.1001/jama.2015.2833

Hepatitis C virus affects an estimated 180 million people worldwide, making it the most common chronic blood-borne pathogen.1 Less than half of infected individuals clear their infection without treatment, and 15% to 40% of patients with HCV progress to cirrhosis or hepatocellular cancer. Hepatitis C virus infection is the most common indication for liver transplantation and is the cause of 8000 to 13 000 deaths in the United States each year.2

First Page Preview View Large
First page PDF preview
First page PDF preview